Affiliation: Imperial College London, UK

Dr. Nazila Kamaly’s research is highly multidisciplinary and uses bioinspired chemical approaches to synthesise multi-functional polymeric nanomedicines, nano-diagnostics or nanotheramostics capable of changing their surface or core properties in response to local or up-regulated disease markers for stimuli-responsive and spatiotemporally controlled biological drug delivery. Her lab also investigates nanomedicine bio-efficacy using microfluidic and lab-on-a-chip systems as in vitro and ex vivo biomimetic models with controlled environmental parameters for testing nanoparticle physicochemical properties. This facilitates a more dynamic biological mechanistic insight between nanoparticles and target cell populations. Dr. Nazila Kamaly has been a lecturer in the Chemistry department since April 2019. Prior to this, she was an Associate Professor at the Technical University of Denmark, Department of Micro and Nanotechnology, where she was awarded a prestigious Lundbeck Fellowship to establish her research group. Before this, she was an instructor and postdoc in the Laboratory of Nanomedicine and Biomaterials at Harvard Medical School and the Laboratory of Prof. Robert Langer at MIT, where she pioneered anti-inflammatory polymeric nanomedicines for heart disease therapy. She also carried out postdoctoral research at Imperial College London Chemistry Department, where she developed nanomedicines, nano diagnostics and nanotheranostics for oncology applications. She obtained an MSci degree in Medicinal Chemistry from University College London, and a PhD in Bioorganic Chemistry from Imperial College London, Department of Chemistry.